0001140361-16-047903.txt : 20160115 0001140361-16-047903.hdr.sgml : 20160115 20160115154735 ACCESSION NUMBER: 0001140361-16-047903 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160115 DATE AS OF CHANGE: 20160115 EFFECTIVENESS DATE: 20160115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OrphoMed, Inc. CENTRAL INDEX KEY: 0001650809 IRS NUMBER: 474519389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1215 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-245663 FILM NUMBER: 161345359 BUSINESS ADDRESS: STREET 1: 806 DENISE COURT CITY: MILL VALLEY STATE: CA ZIP: 94941 BUSINESS PHONE: (949) 275-4478 MAIL ADDRESS: STREET 1: 806 DENISE COURT CITY: MILL VALLEY STATE: CA ZIP: 94941 D/A 1 primary_doc.xml X0707 D/A LIVE 0001650809 OrphoMed, Inc. 806 DENISE COURT MILL VALLEY CA CALIFORNIA 94941 (949) 275-4478 DELAWARE None None Corporation true 2015 Nikhilesh Singh, Ph.D. c/o OrphoMed, Inc., 806 Denise Court Mill Valley CA CALIFORNIA 94941 Executive Officer Director Director, President, Chief Executive Officer and Treasurer Thomas D. Kiley c/o OrphoMed, Inc., 806 Denise Court Mill Valley CA CALIFORNIA 94941 Director Michael Chao c/o OrphoMed, Inc., 806 Denise Court Mill Valley CA CALIFORNIA 94941 Director Biotechnology Decline to Disclose 06b true 0001140361-15-031428 2015-07-28 false true true true true Convertible Promissory Notes, including (i) the shares of Preferred Stock issuable upon conversion of Notes and (ii) the shares of Common Stock issuable upon conversion of Preferred Stock. false 0 2816320 2816012 308 Convertible Promissory Notes were issued in the total aggregate amount of $2,816,012.93 false 10 0 0 0 false OrphoMed, Inc. /s/ Nikhilesh Singh, Ph.D. Nikhilesh Singh, Ph.D. President and Chief Executive Officer 2016-01-15